Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (251-260 of 568) with videos related to

Pageof 57
Sort By:
AIDS (London, England)|July 3, 2009
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyBenoît Marin, Rodolphe Thiébaut, Heiner C Bucher, et al.
Genome Announcements|January 30, 2016
Complete Genome Sequence of KPC-Producing Klebsiella pneumoniae Strain CAV1193Anna E Sheppard, Nicole Stoesser, Robert Sebra, et al.
The Journal of Infection|January 8, 2014
Dynamics of acquisition and loss of carriage of Staphylococcus aureus strains in the community: the effect of clonal complexRuth R Miller, A Sarah Walker, Heather Godwin, et al.
Journal of Medical Microbiology|September 25, 2010
Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, EnglandDona Foster, A Sarah Walker, John Paul, et al.
The Pediatric Infectious Disease Journal|May 29, 2010
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta, Deborah Ford, Veronica Mulenga, et al.
Journal of Neurovirology|September 2, 2015
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trialAlejandro Arenas-Pinto, Jennifer Thompson, Godfrey Musoro, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
AIDS (London, England)|February 1, 2023
Impact of sub-optimal HIV viral control on activated T cellsFrancesca I F Arrigoni, Moira Spyer, Patricia Hunter, et al.
Pageof 57

Showing results (251-260 of 568) with videos related to

Sort By:
Pageof 57
AIDS (London, England)|July 3, 2009
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyBenoît Marin, Rodolphe Thiébaut, Heiner C Bucher, et al.
Genome Announcements|January 30, 2016
Complete Genome Sequence of KPC-Producing Klebsiella pneumoniae Strain CAV1193Anna E Sheppard, Nicole Stoesser, Robert Sebra, et al.
The Journal of Infection|January 8, 2014
Dynamics of acquisition and loss of carriage of Staphylococcus aureus strains in the community: the effect of clonal complexRuth R Miller, A Sarah Walker, Heather Godwin, et al.
Journal of Medical Microbiology|September 25, 2010
Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, EnglandDona Foster, A Sarah Walker, John Paul, et al.
The Pediatric Infectious Disease Journal|May 29, 2010
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta, Deborah Ford, Veronica Mulenga, et al.
Journal of Neurovirology|September 2, 2015
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trialAlejandro Arenas-Pinto, Jennifer Thompson, Godfrey Musoro, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
AIDS (London, England)|February 1, 2023
Impact of sub-optimal HIV viral control on activated T cellsFrancesca I F Arrigoni, Moira Spyer, Patricia Hunter, et al.
Pageof 57